Prediction Case File
YouTubeEvaluation Complete

Ready to Learn from My Mentors? Book a Free Strategy Call at https://felixfriends.org/freedom

5 extracted signals · 5 resolved · 0 still active

Felix & Friends (Goat Academy) profile imageFelix & Friends (Goat Academy)10 Nov 2025, 19:15 UTC
Video preview for Ready to Learn from My Mentors?  Book a Free Strategy Call at https://felixfriends.org/freedom
Signals
5
Eligible signals in this source
Open
0
Still being tracked
Resolved
5
Evaluable outcomes
Successful
3
Canonical correct result
Failed
2
Canonical failed result
Resolved success
60%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video identifies five stocks - A (Agilent Technologies), XOM (Exxon Mobil Corporation), TXG (10x Genomics), DNUT (Krispy Kreme, Inc.), and ZYME (Zymeworks Inc.) - across five different sectors. November is pivotal due to breakthroughs in AI healthcare, energy companies' cash printing, and scientific advancements. A is called an invisible giant powering modern medicine, market growing 7% per year with estimates of US market reaching $269 billion by 2034. It's driven by personalized medicine, pharmaceutical R&D spending, and AI. It is selling the equipment into all of these bio tech companies. Its market is a 52% gross margin; 14.23% ROIC; 16% free cash flow; . In the chart he pointed to a new area around $148. Exxon is trading at about $117, they have massive oil reserves, but he notes analysts say to hold, with a PE ratio of 15.7, but says a lot of money goes back to share holders. Krispy Kreme is at about $4, and he notes that revenue is down due to intentional close downs of stores to streamline profits, to around $40 million. ZYME is at around $16.00, its in clinical stage, and he looks at ADC's in that area.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    5 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Felix & Friends (Goat Academy)

Tracked signals
338
Historical success
59.2%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.